These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36739417)

  • 21. Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs.
    Williams LD; Lee E; Latkin C; Mackesy-Amiti ME; Kaufmann M; Copulsky E; Kaplan C; Boodram B
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the COVID-19 pandemic on access to supervised consumption programs.
    Gubskaya E; Kennedy MC; Hayashi K; Cui Z; Milloy MJ; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):16. PubMed ID: 36899417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
    Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
    Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
    Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
    Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
    Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
    J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
    PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.
    Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D
    Harm Reduct J; 2024 May; 21(1):94. PubMed ID: 38750575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island.
    Tan M; Park C; Goldman J; Biello KB; Buxton J; Hadland SE; Park JN; Sherman SG; Macmadu A; Marshall BDL
    Harm Reduct J; 2024 Feb; 21(1):54. PubMed ID: 38424553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
    Carroll JJ; Marshall BDL; Rich JD; Green TC
    Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of COVID-19 Among People Who Use Drugs: A Qualitative Study With Harm Reduction Workers and People Who Use Drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Res Sq; 2022 Feb; ():. PubMed ID: 35132406
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
    Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
    Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use policy and practice in the COVID-19 pandemic: Learning from early pandemic responses through internationally comparative field data.
    Aronowitz SV; Carroll JJ; Hansen H; Jauffret-Roustide M; Parker CM; Suhail-Sindhu S; Albizu-Garcia C; Alegria M; Arrendondo J; Baldacchino A; Bluthenthal R; Bourgois P; Burraway J; Chen JS; Ekhtiari H; Elkhoy H; Farhoudian A; Friedman J; Jordan A; Kato L; Knight K; Martinez C; McNeil R; Murray H; Namirembe S; Radfar R; Roe L; Sarang A; Scherz C; Tay Wee Teck J; Textor L; Thi Hai Oanh K
    Glob Public Health; 2022 Dec; 17(12):3654-3669. PubMed ID: 36692903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
    Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: A qualitative evaluation.
    Collins AB; Beaudoin FL; Samuels EA; Wightman R; Baird J
    J Subst Abuse Treat; 2021 Nov; 130():108411. PubMed ID: 34118703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "
    Valasek CJ; Streuli SA; Pines HA; Strathdee SA; Borquez A; Bourgois P; Stamos-Buesig T; Vera CF; Harvey-Vera A; Bazzi AR
    Drug Alcohol Depend Rep; 2023 Jun; 7():100154. PubMed ID: 37089868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
    Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
    Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in self-reported non-fatal overdose and patterns of substance use before and during the COVID-19 pandemic in a prospective cohort of adults who have injected drugs - Baltimore, Maryland, 2014-2022.
    Feder KA; Patel EU; Buresh M; Kirk GD; Mehta SH; Genberg BL
    Drug Alcohol Depend; 2023 Oct; 251():110954. PubMed ID: 37716287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada.
    Moallef S; Genberg BL; Hayashi K; Mehta SH; Kirk GD; Choi J; DeBeck K; Kipke M; Moore RD; Baum MK; Shoptaw S; Gorbach PM; Mustanski B; Javanbakht M; Siminski S; Milloy MJ
    Drug Alcohol Depend; 2022 Dec; 241():109633. PubMed ID: 36171158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.